In vivo model for dyslipidemia with diabetes mellitus in hamster

Indian Journal of Experimental Biology

Volumn 41, Issue 12, 2003, Pages 1456-1459

  Bhatia, Gitika ^a   Rizvi, Farhan ^a   Saxena, Rashmi ^a   Puri, Anju ^a   Khanna, A K ^a   Chander, Ramesh ^a   Wulff, E M ^b   Rastogi, A K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Diabetes; Dyslipidemia; Hyperglycemia; In vivo model; Lipid lowering drugs

Indexed keywords

CHOLESTEROL; DISEASES; DRUG PRODUCTS; FATTY ACIDS; GLYCEROL; METABOLISM; NUTRITION; PROTEINS;

HYPOGLYCEMIC ACTIVITY;

LIPIDS;

ANTILIPEMIC AGENT; FENOFIBRATE;

ANIMAL; ARTICLE; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; FAT INTAKE; HAMSTER; HYPERLIPIDEMIA;

ANIMALS; ANTILIPEMIC AGENTS; CRICETINAE; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS; DISEASE MODELS, ANIMAL; HYPERLIPIDEMIAS; PROCETOFEN;

ANIMALIA; CRICETINAE;

EID: 0345598887     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mordes J P & Kossini A A, Animal models in diabetes, Am J Med, 70 (1981) 353.
2. Shukla R, Sharma S B, Puri D Murthy P S, Medicinal plants for treatment of diabetes mellitus, Indian J Clin Biochem, 15(Suppl) (2000) 169.
3. Elkeles R S, Diamond J R, Poulter C, Dhanjel S, Nicolaids A N, Mehmood S & The SENDCAP study group, cardiovascular outcome in type 2 diabetes. A double-blind placebo controlled study of bezafibrate, Diabetes Care, 21 (1998) 641.
4. Fredrick D S, Levg RI & Lees R S, Fat transport in lipoprotein-an integrated approach to mechanism and disorders, New Engl J Med, 276 (1967) 273.
5. Chakraverti R N & Sharda N, Animal models of atherosclerosis-A review, Lab Animals India, 1 (1991) 3.
6. Beher W T, Bajer G D & Penney D G, A comparative study of the effects of bile acids and cholesterol on cholesterol metabolism in the mouse, rat, hamster and guinea pig, J Nutrition, 79 (1963) 523.
7. Bordia A, Verma S K, Vyas A K, Khabya B L, Rathose A S, Bhu N & Bedi H K, Effect of essential oil of onion and garlic on experimental atherosclerosis, Atherosclerosis, 26 (1977) 379.
8. Jain R C & Konar D B, Effect of garlic oil in experimental cholesterol atherosclerosis, Atherosclerosis, 29 (1978) 125.
9. Yagi N, Takasu N, Higa S, Ishikwa K, Murakami K & Mimura G, Effect of Troglitazone, a new oral antidiabetic agent on fructose-induced insulin resistance, Horm Metab Res, 27 (1995) 439.
10. Overturf M L & Mitchell D S L, In vivo model systems: the choice of the expermental animal model for analysis of lipoproteins and atherosclerosis, Curr Opinion Lipidol, 3 (1992) 179.
11. Deeg R & Ziegenhorn J, Kinetic enzymetic method for automated determination of total cholesterol in serum, Clin Chem, 29 (1983) 1798.
12. Buccolo G & David H, Quantitative determination of serum triglycerides by the use of enzymes, Clin Chem, 19 (1973) 476.
13. Gordon D J, Probstfield J L, Garrison R J, Neaton J D, Jacobs D R, Jr Bangdiwala S & Tyroler H A, High-density lipoprotein cholesterol and cardiovascular Disease: four prospective American studies, Circulation, 79(1989) 8.
14. Mc Gowan M W, Artiss J D, Strandbergh D R & Zak B, A peroxidase coupled method for the colorimetric determination of glycerol, Clin Chem, 29 (1983) 538.
15. Trinder P, Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor, Ann Clin Biochem, 6 (1969) 24.
16. Wako pure Chemicals Ltd. NAFAC, Quantitative determination of free fatty acid in serum by ACS-ACOD method Company Code No. 994-75409E.
17. Goldstein D E, Oarjer J N & England J D, Clinical application of glycosylated hemoglobin measurements, Diabetes, 31 (1982) 70.
18. Friedwald W T, Levy R I & Fredrickson D S, Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultra centrifuge, Clin Chem 18 (1972) 499.
19. Knapka J J & Judge F J, The effects of various levels of dietary fat and apple supplements on growth of golden hamsters (Mesocricetus auratus), Lab Anim Sci, 24 (1974) 318.
20. Nakamura T, Funohashi T, Yamashita S & Nishida M et al., Thiozolidinedione derivatives improves fat distribution and multiple risk factors in subjects with visceral fat accumulation-double-blind placebo-controlled trial, Diabetes Res Clin Pract, 54 (2001) 181.
21. Rossini A A, Arcangeli M A & Cahill G F Jr, Studies of alloxan toxicity on the beta cell diabetes, Diabetes, 24 (1975) 516.
22. Duff G L & Murray EG D, The pathology of the pancreas in experimetal diabetes mellitus, Am J Med Sci, 210 (1945) 81.
23. Staels B, Dallongeville J, Auverx J, Shoonjans K, Leitersdorf E & Fruchart J C, Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation, 98 (1998) 2088.